skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer

Journal Article · · Nature Communications
DOI:https://doi.org/10.1038/ncomms7605· OSTI ID:1236642
 [1];  [2];  [3]; ORCiD logo [4];  [5];  [6]; ORCiD logo [7];  [6];  [8];  [9];  [9];  [6];  [6];  [6];  [1];  [10];  [1];  [1]; ORCiD logo [1];  [11] more »;  [12];  [12];  [9];  [13];  [14];  [15];  [1];  [1];  [1] « less
  1. Royal Melbourne Hospital and Univ. of Melbourne, Victoria (Australia); Epworth Hospital, Victoria (Australia)
  2. Univ. of Melbourne, Victoria (Australia); Univ. of Cambridge, Cambridge (United Kingdom)
  3. Wellcome Trust Sanger Institute, Hinxton (United Kingdom)
  4. Wellcome Trust Sanger Institute, Hinxton (United Kingdom); KU Leuven, Leuven (Belgium), Cancer Research UK London Research Institute, London (United Kingdom)
  5. Univ. of Cambridge, Cambridge (United Kingdom); Cambridge Univ., Cambridge (United Kingdom)
  6. Univ. of Melbourne, Victoria (Australia)
  7. Wellcome Trust Sanger Institute, Hinxton (United Kingdom); Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  8. Royal Melbourne Hospital and Univ. of Melbourne, Victoria (Australia); Epworth Hospital, Victoria (Australia); Univ. of Melbourne, Victoria (Australia)
  9. Univ. of Cambridge, Cambridge (United Kingdom)
  10. Royal Melbourne Hospital, Victoria (Australia)
  11. Univ. Cambridge Hospitals, Cambridge (United Kingdom)
  12. Univ. of Cambridge, Cambridge (United Kingdom); Addenbrookes Hospital, Cambridge Univ., Hospitals NHS Foundation Trust, Cambridge (United Kingdom)
  13. TissuPath Specialist Pathology, Victoria (Australia); Monash Univ. Faculty of Medicine, Victoria (Australia)
  14. TissuPath Specialist Pathology, Victoria (Australia)
  15. Bar-Ilan Univ. Medical School, Safad (Israel)

Tumour heterogeneity in primary prostate cancer is a well-established phenomenon. However, how the subclonal diversity of tumours changes during metastasis and progression to lethality is poorly understood. Here we reveal the precise direction of metastatic spread across four lethal prostate cancer patients using whole-genome and ultra-deep targeted sequencing of longitudinally collected primary and metastatic tumours. We find one case of metastatic spread to the surgical bed causing local recurrence, and another case of cross-metastatic site seeding combining with dynamic remoulding of subclonal mixtures in response to therapy. By ultra-deep sequencing end-stage blood, we detect both metastatic and primary tumour clones, even years after removal of the prostate. As a result, analysis of mutations associated with metastasis reveals an enrichment of TP53 mutations, and additional sequencing of metastases from 19 patients demonstrates that acquisition of TP53 mutations is linked with the expansion of subclones with metastatic potential which we can detect in the blood.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1236642
Report Number(s):
LA-UR-14-29031; ncomms7605
Journal Information:
Nature Communications, Vol. 6, Issue C; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 259 works
Citation information provided by
Web of Science

References (68)

The genomic complexity of primary human prostate cancer journal February 2011
Integrative Genomic Profiling of Human Prostate Cancer journal July 2010
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer journal May 2012
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer journal February 2013
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers journal September 2011
The mutational landscape of lethal castration-resistant prostate cancer journal May 2012
Punctuated Evolution of Prostate Cancer Genomes journal April 2013
Distant metastasis occurs late during the genetic evolution of pancreatic cancer journal October 2010
The patterns and dynamics of genomic instability in metastatic pancreatic cancer journal October 2010
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution journal October 2014
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing journal October 2014
The Life History of 21 Breast Cancers journal May 2012
Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients journal December 2005
The Syk tyrosine kinase: A new negative regulator in tumor growth and progression journal September 2006
Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer journal January 2011
Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma journal December 2008
Recurrent PTPRB and PLCG1 mutations in angiosarcoma journal March 2014
Mutational signatures: the patterns of somatic mutations hidden in cancer genomes journal February 2014
Signatures of mutational processes in human cancer journal August 2013
Mutational Processes Molding the Genomes of 21 Breast Cancers journal May 2012
Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements journal December 2013
Chromoplexy: A New Category of Complex Rearrangements in the Cancer Genome journal May 2013
Germline and somatic polymerase ϵ and δ mutations define a new class of hypermutated colorectal and endometrial cancers: DNA polymerase mutations in colorectal and endometrial cancers journal May 2013
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas journal December 2012
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer journal September 2014
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA journal May 2012
Tumor clone dynamics in lethal prostate cancer journal September 2014
Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome journal December 2004
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome journal December 2004
P53 expression in breast cancer journal February 1988
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade journal May 2014
The prostate cancer genome: Perspectives and potential journal January 2014
The Mutational Landscape of Prostate Cancer journal October 2013
Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification journal May 2013
The complexity of prostate cancer: genomic alterations and heterogeneity journal November 2012
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade journal September 2012
Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer: Genetic intratumoural heterogeneity in unifocal prostate cancer journal July 2014
Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology journal October 2013
SomaticSniper: identification of somatic point mutations in whole genome sequencing data journal December 2011
Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays journal November 2009
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads journal January 2014
Allele-specific copy number analysis of tumors journal September 2010
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies journal June 2009
The 1000 Genomes Project: data management and community access journal April 2012
Fast and accurate short read alignment with Burrows-Wheeler transform journal May 2009
RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics journal June 2012
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions journal January 2013
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome journal January 2009
Deciphering Signatures of Mutational Processes Operative in Human Cancer journal January 2013
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma journal January 2014
A census of human cancer genes journal March 2004
Comprehensive identification of mutational cancer driver genes across 12 tumor types journal October 2013
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data journal July 2010
SPOCD1 is an essential executor of piRNA-directed de novo DNA methylation journal July 2020
Database resources of the National Center for Biotechnology Information journal January 2006
Impact of concurrency on the performance of a whole exome sequencing pipeline journal February 2021
Allele-specific copy number analysis of tumors text January 2010
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. text January 2014
The life history of 21 breast cancers. journalarticle January 2012
Deciphering signatures of mutational processes operative in human cancer. text January 2013
The Life History of 21 Breast Cancers journal August 2015
Database resources of the National Center for Biotechnology Information journal October 2020
Signatures of mutational processes in human cancer. text January 2013
Database resources of the National Center for Biotechnology Information journal December 2007
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer text January 2012
Database resources of the National Center for Biotechnology Information journal November 2018
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions text January 2013
Prostate Cancer Genomics: Progress and Promise journal October 2013

Cited By (71)

Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer journal November 2019
Transcriptional profiling of breast cancer‐associated lymphatic vessels reveals VCAM‐1 as regulator of lymphatic invasion and permeability journal February 2019
Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting journal October 2018
A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy journal January 2020
Clinical implications of intratumor heterogeneity: challenges and opportunities journal January 2020
Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques journal November 2017
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time journal December 2018
Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection journal June 2019
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death journal June 2017
The Genomics of Prostate Cancer: emerging understanding with technologic advances journal January 2018
The complex seeds of metastasis journal April 2015
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer journal June 2016
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations journal April 2017
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer journal January 2017
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence journal January 2018
Targeting metastasis journal March 2016
Bone metastasis: the importance of the neighbourhood journal May 2016
Genetic insights into the morass of metastatic heterogeneity journal February 2018
Translational and clinical implications of the genetic landscape of prostate cancer journal June 2016
Tumour heterogeneity and resistance to cancer therapies journal November 2017
The evolution of tumour phylogenetics: principles and practice journal February 2017
Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer journal July 2016
The effects of mutational processes and selection on driver mutations across cancer types journal May 2018
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity journal June 2018
Translational models of prostate cancer bone metastasis journal May 2018
Mutations in BRCA2 and taxane resistance in prostate cancer journal July 2017
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer journal July 2017
Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence journal March 2017
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy journal October 2019
Understanding mutagenesis through delineation of mutational signatures in human cancer journal May 2016
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer journal June 2017
Radiation resistant cancer cells enhance the survival and resistance of sensitive cells in prostate spheroids posted_content March 2019
Prostate Stem Cells and Cancer Stem Cells journal October 2018
Genetics and biology of prostate cancer journal September 2018
Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression journal October 2018
Metastasis as an evolutionary process journal April 2016
Minimal functional driver gene heterogeneity among untreated metastases journal September 2018
Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture journal July 2016
Frequent clonal relations between metastases and non-index prostate cancer lesions journal January 2019
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer journal February 2016
Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status journal May 2017
p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition journal July 2019
Timing somatic events in the evolution of cancer journal July 2018
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE” journal December 2016
Stem cells in genetically-engineered mouse models of prostate cancer journal September 2015
Clonal origin and spread of metastatic prostate cancer journal April 2016
Precision Oncology: The Promise of Big Data and the Legacy of Small Data journal August 2017
Sleeping Beauty Mouse Models of Cancer: Microenvironmental Influences on Cancer Genetics journal July 2019
Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis journal December 2016
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications journal July 2019
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer journal August 2017
Developments in oligometastatic hormone-sensitive prostate cancer journal October 2018
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread text January 2018
Transcriptional profiling of breast cancer-associated lymphatic vessels reveals VCAM-1 as regulator of lymphatic invasion and permeability text January 2019
Clinical implications of intratumor heterogeneity: challenges and opportunities text January 2020
The Genomics of Prostate Cancer: emerging understanding with technologic advances. text January 2018
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer text January 2017
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread text January 2018
The effects of mutational processes and selection on driver mutations across cancer types posted_content June 2017
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread journal August 2018
Transcriptional profiling of breast cancer-associated lymphatic vessels reveals VCAM-1 as regulator of lymphatic invasion and permeability. text January 2019
Clinical implications of intratumor heterogeneity: challenges and opportunities text January 2020
Oligometastatic prostate cancer: Reality or figment of imagination? journal December 2018
Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144] journal March 2017
Comparing nodal versus bony metastatic spread using tumour phylogenies journal September 2016
The role of chemotherapy and new targeted agents in the management of primary prostate cancer journal December 2016
Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures journal November 2017
Molecular determinants of prostate cancer metastasis journal September 2017
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology journal July 2018
Phylogenetic Tree Inference: A Top-Down Approach to Track Tumor Evolution journal February 2020
Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer journal November 2017

Similar Records

BRCA1 loss pre-existing in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood
Technical Report · Fri Mar 19 00:00:00 EDT 2010 · OSTI ID:1236642

Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Journal Article · Mon Jun 22 00:00:00 EDT 2015 · Nature Medicine · OSTI ID:1236642

Predictors of Metastatic Disease After Prostate Brachytherapy
Journal Article · Fri Jun 01 00:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:1236642